SecBot SecBot
SECBOTREPLAY Home › Report › PEPG

PEPG · $125M priced equity offering

PepGen Inc. · 424B5 filed Nov 12, 2026 at 16:30 ET

At the news

BEARISHIMPACT 6/10

424B5 filed Nov 12, 2026 at 16:30 ET

PepGen is offering 25,000,000 shares of common stock at $5.00 per share in a priced underwritten equity offering, raising gross proceeds of $125 million ($116.9 million net). The offering represents a 36.1% dilution to the 69,261,055 shares outstanding as of September 30, 2026. Proceeds will fund clinical development of PGN-EDODM1 and general corporate purposes. The offering follows positive Phase 2 FREEDOM2-DM1 results reported on November 10, 2026, and comes two days after that earnings release, signaling an urgent capital need despite the positive data.

  • Offering of 25,000,000 shares of common stock at $5.00 per share
  • Gross proceeds of $125,000,000; net proceeds of approximately $116,900,000
  • Underwriters have a 30-day option to purchase up to an additional 3,750,000 shares
  • Shares outstanding after offering: 94,261,055 (or 98,011,055 if option exercised in full)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access